Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Biotech
FDA's CMO steps down
Before leading as the FDA's CMO, Marston was a senior advisor on the White House COVID-19 response team.
Gabrielle Masson
Apr 2, 2025 10:02am
Pliant terminates lung disease trial due to adverse events
Mar 3, 2025 11:30am
Neurogene acts as gene therapy puts person in critical condition
Nov 18, 2024 8:33am
Syndax stock slips after AML drug hits midstage trial goal
Nov 12, 2024 2:00pm
Novartis' $2.9B MorphoSys bet stumbles as safety delays filing
Oct 29, 2024 6:16am
Karuna's schizophrenia drug clears blood pressure test
Nov 17, 2023 8:52am
